Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?

Table 3 Studies on transcatheter arterial chemoembolization + portal venous embolizations and the rate of conversion to resection

Ref.	Year	Cases	Types of tumor	Convert to surgery (%)	5-yr disease-free survival rates (%)	Median survival time (mo)
[101]	2004	17	Hepatocellular carcinoma	94	46.7	NM
[102]	2006	18	Hepatocellular carcinoma	100	37	NM
[113]	2011	71	Hepatocellular carcinoma	95.7	61	NM
[103]	2012	29	Hepatocellular carcinoma and metastatic disease	93.1	NM	58
[104]	2016	54	Hepatocellular carcinoma	72	NM	41

NM: Not mentioned.